BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29527661)

  • 1. Cutaneous seeding of neoplastic plasma cells to a site of bruising in a patient with relapsed myeloma.
    Boyle S; Hourigan M
    Br J Haematol; 2018 Jun; 181(6):723. PubMed ID: 29527661
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secondary cutaneous plasmacytoma revealing multiple myeloma: about a case].
    Ngolet LO; N'soundhat NL; Ndounga E; Kocko I; Kidédé DC; Ntsiba H
    Pan Afr Med J; 2016; 24():44. PubMed ID: 27642385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous plasmacytomas in myeloma. Relationship to tumor cell burden.
    Alberts DS; Lynch P
    Arch Dermatol; 1978 Dec; 114(12):1784-7. PubMed ID: 736585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple myeloma with skin involvement.
    Güvenç B; Canataroğlu A; Gümürdülü Y; Gümürdülü D; Paydaşt S
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):328-9. PubMed ID: 11730044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giant cutaneous plasmacytoma of the sacrococcygeal region.
    Ioannidis O; Kakoutis E; Varnalidis I; Tamouridis G; Chatzichristou A; Tzarou V; Makrantonakis N
    J Cutan Med Surg; 2010; 14(2):90-4. PubMed ID: 20338125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The cellular substratum in plasmacytoma].
    Micu D
    Stud Cercet Med Interna; 1971; 12(6):511-22. PubMed ID: 4944649
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous Nodules in Multiple Myeloma. Cutaneous plasmacytoma associated with multiple myeloma.
    Gómez-Armayones S; Climent F; Servitje O
    Actas Dermosifiliogr; 2015 Sep; 106(7):581-2. PubMed ID: 25935193
    [No Abstract]   [Full Text] [Related]  

  • 8. Is multidrug resistance (P-glycoprotein) an intrinsic characteristic of plasma cells in patients with monoclonal gammopathy of undetermined significance, plasmacytoma, multiple myeloma and amyloidosis?
    Mongkonsritragoon W; Kimlinger T; Ahmann G; Greipp PR
    Leuk Lymphoma; 1998 May; 29(5-6):577-84. PubMed ID: 9643571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?
    Marchica V; Accardi F; Storti P; Mancini C; Martella E; Dalla Palma B; Bolzoni M; Todoerti K; Marcatti M; Schifano C; Bonomini S; Sammarelli G; Neri A; Ponzoni M; Aversa F; Giuliani N
    Int J Hematol; 2017 Jan; 105(1):104-108. PubMed ID: 27699576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extramedullary cutaneous plasmacytoma.
    Ceccolini E; Palmerio B; Patrone P
    Cutis; 1991 Aug; 48(2):134-6. PubMed ID: 1935238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic study of cutaneous plasmacytoma.
    Torne R; Su WP; Winkelmann RK; Smolle J; Kerl H
    Int J Dermatol; 1990 Oct; 29(8):562-6. PubMed ID: 2242944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous plasmacytoma.
    Matsuda M; Sueda S; Taniguchi T
    Int J Hematol; 2017 May; 105(5):545-546. PubMed ID: 28247190
    [No Abstract]   [Full Text] [Related]  

  • 13. CD31 expression in plasmacytic/plasmablastic lesions.
    Plocharczyk E; Wakely PE
    Ann Diagn Pathol; 2013 Dec; 17(6):498-501. PubMed ID: 24074836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large neglected ulcerated melanoma mimicking extramedullary plasmacytoma.
    Lehmer LM; Ragsdale BD; Frost MV; Ferguson KL
    Am J Dermatopathol; 2011 Dec; 33(8):e94-8. PubMed ID: 22008718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous plasmablastic plasmacytoma.
    Chung A; Liedtke M
    Blood; 2019 Dec; 134(23):2116. PubMed ID: 31805196
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of syndecan-1 is a sensitive marker for cutaneous plasmacytoma.
    Bayer-Garner IB; Joseph L; Sanderson RD; Smoller BR
    J Cutan Pathol; 2003 Jan; 30(1):18-22. PubMed ID: 12534799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cutaneous plasmacytoma with eventual development into multiple myeloma].
    Kanoh T; Michishita M; Imada K; Ohnaka T; Uchino H
    Nihon Naika Gakkai Zasshi; 1987 Nov; 76(11):1706-9. PubMed ID: 3509170
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple myeloma first presenting as cutaneous plasmacytoma.
    Hauschild A; Haferlach T; Löffler H; Christophers E
    J Am Acad Dermatol; 1996 Jan; 34(1):146-8. PubMed ID: 8543686
    [No Abstract]   [Full Text] [Related]  

  • 19. Catheter insertion site plasmacytoma.
    Arango M; Echeverri C
    Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):34-5. PubMed ID: 26276079
    [No Abstract]   [Full Text] [Related]  

  • 20. Extensive and progressive cutaneous plasmacytoma in plateau phase myeloma.
    Jedlicka M; Owen RG; Follows G; Parapia LA
    Clin Lab Haematol; 1998 Oct; 20(5):321-2. PubMed ID: 9807683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.